Peptides Restore Functional State of the Kidneys During Cisplatin-Induced Acute Renal Failure

Bulletin of Experimental Biology and Medicine

Volumn 159, Issue 6, 2015, Pages 736-739

  Zamorskii, I I ^a   Shchudrova, T S ^a   Lin'kova N S ^c,d   Nichik, T E ^d   Khavinson, V Kh ^b,c  

^a BUKOVINIAN STATE MEDICAL UNIVERSITY   (Ukraine)

^b NORTH WESTERN STATE MEDICAL UNIVERSITY NAMED AFTER I I MECHNIKOV   (Russian Federation)

^c PETER THE GREAT ST PETERSBURG POLYTECHNIC UNIVERSITY   (Russian Federation)

^d St Petersburg Institute of Bioregulation and Gerontology   (Russian Federation)

Author keywords

acute renal failure; cisplatin; peptides

Indexed keywords

CISPLATIN; PEPTIDE AED; PEPTIDE AEDG; PEPTIDE EDL; POLYPEPTIDE; POLYPEPTIDE COMPLEX FROM THE KIDNEY; POTASSIUM; SODIUM; UNCLASSIFIED DRUG; CREATININE; PEPTIDE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HYPOKALEMIA; INFANT; KIDNEY FUNCTION; NONHUMAN; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; RAT; SINGLE DRUG DOSE; SODIUM BLOOD LEVEL; SODIUM EXCRETION; URINALYSIS; ACUTE KIDNEY INJURY; ANIMAL; CELL PROTECTION; CHEMICALLY INDUCED; DIURESIS; DRUG EFFECTS; KIDNEY; OUTBRED STRAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE;

ACUTE KIDNEY INJURY; ANIMALS; ANIMALS, OUTBRED STRAINS; CISPLATIN; CREATININE; CYTOPROTECTION; DIURESIS; GLOMERULAR FILTRATION RATE; KIDNEY; PEPTIDES; POTASSIUM; RATS; SODIUM;

EID: 84957838082     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-015-3062-y     Document Type: Article

References (15)

1. A. I. Gozhenko, Patologiya, 5, No. 3, 66-75 (2008).
2. V. V. Khavinson, V. V. Malinin, and G. A. Ryzhak, Eurasian Patent No. 010723, Substance Normalizing Renal Function and Method of Its Synthesis, October 30, 2008.
3. V. S. Kamyshnikova, Manual for Clinical and Biochemical Analysis and Laboratory Diagnostics [in Russian], Moscow (2009).
4. T. E. Nichuk, N. S. Lin’kova, N. A. Kraskovskaya, et al., Uspekhi Fiziol. Nauk, 45, No. 2, 49-56 (2014).
5. O. O. Petyuk, N. I. Voloshchuk, and O. V. Mashevs’ka, Rats. Farmakoter., No. 1, 6-15 (2009).
6. S. I. Ryabov and Yu. V. Natochkin, Functional Neurology [in Russian], St. Petersburg (1997).
7. V. Kh. Khavintson, N. S. Lin’kova, V. O. Polyakova, et al., Bull. Exp. Biol. Med., 157, No. 2, 261-264 (2014).
8. S. Yu. Schtrigol’, V. M. Lisovii, and I. A. Zupanen’, Methods for Experimental Modeling of Kidney Failure in Pharmacological Studies [in Ukrainian], Kiev (2009).
9. V. Kh. Khavinson, N. S. Linkova, A. V. Trofimov, et al., Biol. Bull. Rev., 1, No. 4, 389-393 (2011).
10. U. Kilic, E. Kilic, Z. Tuzcu, et al., Nutr. Metab. (Lond.), 10, No. 1, 7 (2013).
11. R. P. Miller, R. K. Tadagavadi, G. Ramesh, and W. B. Reeves, Toxins (Basel), 2, No. 11, 2490-2518 (2010).
12. N. Pabla, and Z. Dong, Kidney Int., 73, No. 9, 994-1007 (2008).
13. A. P. Singh, A. Junemann, A. Muthuraman, et al., Pharmacol. Rep., 64, No. 1, 31-44 (2012).
14. X. Yao, K. Panichpisal, N. Kurtzman, and K. Nugent, Am. J. Med. Sci., 334, No. 2, 115-124 (2007).
15. I. I. Zamorskii, and T. S. Shchudrova, Biophysics, 59, No. 5, 834-836 (2014).